Bradley Canino

Stock Analyst at Stifel

(0)
# 4687
Out of 5,319 analysts
102
Total ratings
17.86%
Success rate
-23.54%
Average return
Main Sectors:
Top Industries:
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
BDTX Black Diamond Therap...
Maintains: Buy
16 15
1.45 934.48% 5 Mar 7, 2025
ALXO ALX Oncology Holding...
Maintains: Hold
3 2
0.54 177.78% 8 Mar 7, 2025
RLAY Relay Therapeutics
Maintains: Buy
27 23
2.69 755.02% 5 Feb 27, 2025
ARVN Arvinas
Maintains: Buy
63 51
8.6 493.02% 6 Feb 12, 2025
JANX Janux Therapeutics
Maintains: Strong Buy
70 115
29.61 288.38% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 4
0.73 447.95% 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 41
11.51 256.21% 5 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
26 19
5.88 223.13% 6 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
39 42
10.27 308.96% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
24.61 62.54% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
71.67 88.36% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
4.76 320.17% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
0.96 941.67% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.29 675.19% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
43.02 130.13% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
1.24 1029.03% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
7.89 406.97% 1 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
84.69 53.5% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
26 111.54% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
n/a n/a 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022